Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$84.70
0.670.80%
al cierre: -
$85.35
0.650.77%
After hour: Aug 15, 6:45 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Crocs Inc ha un obiettivo di prezzo di consenso pari a $118.13, stabilito in base alle ultime valutazioni degli analisti di 19. Le ultime 3 valutazioni degli analisti sono state rilasciate da UBS, Keybanc y B of A Securities il agosto 11, 2025, agosto 8, 2025 y agosto 8, 2025. Con un obiettivo di prezzo medio di $93 tra le UBS, Keybanc y B of A Securities, c'è un implicito 8.96% upside per Crocs Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
UBS
Keybanc
B of A Securities
Stifel
Barclays
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Crocs
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/11/2025 | -0.41% | UBS | $110 → $85 | Maintains | Neutral | |||
08/08/2025 | 11.31% | Keybanc | $120 → $95 | Maintains | Overweight | |||
08/08/2025 | 15.99% | B of A Securities | $135 → $99 | Maintains | Buy | |||
08/08/2025 | -0.41% | Stifel | $127 → $85 | Downgrade | Buy → Hold | |||
08/08/2025 | -5.1% | Barclays | $119 → $81 | Downgrade | Overweight → Equal-Weight | |||
08/07/2025 | 4.28% | Needham | $129 → $89 | Maintains | Buy | |||
07/28/2025 | 28.88% | UBS | $105 → $110 | Maintains | Neutral | |||
07/22/2025 | 1.93% | Goldman Sachs | $88 → $87 | Maintains | Sell | |||
07/02/2025 | 3.1% | Goldman Sachs | → $88 | Initiates | → Sell | |||
06/30/2025 | 58.17% | B of A Securities | $140 → $135 | Maintains | Buy | |||
05/09/2025 | 39.42% | Barclays | $122 → $119 | Maintains | Overweight | |||
05/08/2025 | 51.14% | Needham | $118 → $129 | Maintains | Buy | |||
05/01/2025 | 38.25% | Needham | $129 → $118 | Maintains | Buy | |||
04/11/2025 | 34.74% | Piper Sandler | $125 → $115 | Maintains | Overweight | |||
04/10/2025 | 48.8% | Stifel | $138 → $127 | Maintains | Buy | |||
03/12/2025 | 28.88% | Loop Capital | $110 → $110 | Upgrade | Hold → Buy | |||
02/19/2025 | 54.66% | UBS | $122 → $132 | Maintains | Neutral | |||
02/14/2025 | 42.94% | Barclays | $125 → $122 | Maintains | Overweight | |||
02/14/2025 | 79.26% | B of A Securities | $144 → $153 | Maintains | Buy | |||
02/13/2025 | 51.14% | Needham | $129 → $129 | Reiterates | Buy → Buy | |||
02/10/2025 | 75.74% | Baird | $180 → $150 | Maintains | Outperform | |||
02/03/2025 | 75.74% | Guggenheim | $155 → $150 | Maintains | Buy | |||
01/23/2025 | 40.6% | Keybanc | $150 → $120 | Maintains | Overweight | |||
01/06/2025 | 68.72% | B of A Securities | $147 → $144 | Maintains | Buy | |||
12/06/2024 | 81.6% | Guggenheim | $155 → $155 | Reiterates | Buy → Buy | |||
11/22/2024 | 35.91% | Needham | → $116 | Initiates | → Buy | |||
11/07/2024 | 28.88% | Loop Capital | $150 → $110 | Downgrade | Buy → Hold | |||
10/30/2024 | 81.6% | Guggenheim | $182 → $155 | Maintains | Buy | |||
10/30/2024 | 75.74% | Loop Capital | $155 → $150 | Maintains | Buy | |||
10/30/2024 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/30/2024 | 75.74% | Keybanc | $155 → $150 | Maintains | Overweight | |||
10/30/2024 | 42.94% | UBS | $146 → $122 | Maintains | Neutral | |||
10/30/2024 | 110.89% | Baird | $190 → $180 | Maintains | Outperform | |||
10/29/2024 | 46.45% | Barclays | $164 → $125 | Maintains | Overweight | |||
10/09/2024 | 113.24% | Guggenheim | → $182 | Initiates | → Buy | |||
09/26/2024 | 81.6% | Keybanc | $149 → $155 | Maintains | Overweight | |||
08/23/2024 | 99.18% | Piper Sandler | → $170 | Assumes | → Overweight | |||
08/22/2024 | 90.98% | Williams Trading | $135 → $163 | Upgrade | Hold → Buy | |||
08/02/2024 | 92.15% | Raymond James | $164 → $164 | Downgrade | Strong Buy → Outperform | |||
08/02/2024 | 92.15% | Barclays | $169 → $164 | Maintains | Overweight | |||
07/29/2024 | 99.18% | Wedbush | $170 → $170 | Reiterates | Outperform → Outperform | |||
07/16/2024 | 71.06% | UBS | $148 → $146 | Maintains | Neutral | |||
06/20/2024 | 119.1% | B of A Securities | $160 → $187 | Maintains | Buy | |||
05/13/2024 | 99.18% | Wedbush | $156 → $170 | Maintains | Outperform | |||
05/08/2024 | 98.01% | Barclays | $167 → $169 | Maintains | Overweight | |||
05/08/2024 | 85.12% | Stifel | $140 → $158 | Maintains | Buy | |||
05/08/2024 | 73.4% | UBS | $124 → $148 | Maintains | Neutral | |||
05/07/2024 | 82.77% | Wedbush | $154 → $156 | Maintains | Outperform | |||
05/03/2024 | 80.43% | Wedbush | $154 → $154 | Reiterates | Outperform → Outperform | |||
04/23/2024 | 45.28% | UBS | $117 → $124 | Maintains | Neutral | |||
04/16/2024 | 46.45% | Williams Trading | $135 → $125 | Downgrade | Buy → Hold | |||
04/11/2024 | — | OTR Global | — | — | Upgrade | Mixed → Positive | ||
04/10/2024 | 42.94% | B. Riley Securities | $95 → $122 | Maintains | Neutral | |||
04/01/2024 | 95.66% | Barclays | → $167 | Initiates | → Overweight | |||
03/21/2024 | 74.57% | Keybanc | $130 → $149 | Maintains | Overweight | |||
03/20/2024 | 75.74% | B of A Securities | $140 → $150 | Maintains | Buy | |||
02/16/2024 | 80.43% | Wedbush | $136 → $154 | Maintains | Outperform | |||
02/16/2024 | 11.31% | B. Riley Securities | $93 → $95 | Maintains | Neutral | |||
02/16/2024 | 64.03% | Piper Sandler | $135 → $140 | Maintains | Overweight | |||
02/16/2024 | 69.89% | Raymond James | $120 → $145 | Maintains | Strong Buy | |||
02/16/2024 | 64.03% | Stifel | $132 → $140 | Maintains | Buy | |||
01/09/2024 | 40.6% | Raymond James | $115 → $120 | Maintains | Strong Buy | |||
01/08/2024 | 59.34% | Wedbush | $120 → $136 | Maintains | Outperform | |||
12/14/2023 | 54.66% | Stifel | $121 → $132 | Maintains | Buy | |||
12/12/2023 | 49.97% | B of A Securities | → $128 | Initiates | → Buy | |||
12/01/2023 | 40.6% | Wedbush | $96 → $120 | Maintains | Outperform | |||
11/28/2023 | 34.74% | Raymond James | $98 → $115 | Upgrade | Outperform → Strong Buy | |||
10/20/2023 | 28.88% | Raymond James | → $110 | Upgrade | Market Perform → Outperform | |||
10/04/2023 | — | OTR Global | — | — | Downgrade | Positive → Mixed | ||
09/19/2023 | 55.83% | Wedbush | → $133 | Reiterates | Outperform → Outperform | |||
09/07/2023 | 18.33% | B. Riley Securities | $125 → $101 | Downgrade | Buy → Neutral | |||
08/01/2023 | 55.83% | Wedbush | → $133 | Reiterates | Outperform → Outperform | |||
07/28/2023 | 52.31% | Stifel | → $130 | Upgrade | Hold → Buy | |||
07/27/2023 | 79.26% | Wedbush | → $153 | Reiterates | Outperform → Outperform | |||
07/24/2023 | 79.26% | Wedbush | → $153 | Reiterates | Outperform → Outperform | |||
07/13/2023 | 79.26% | Wedbush | → $153 | Reiterates | Outperform → Outperform | |||
06/14/2023 | — | Raymond James | — | Initiates | → Market Perform | |||
04/28/2023 | 86.29% | B. Riley Securities | $157 → $159 | Maintains | Buy | |||
04/28/2023 | 116.75% | Baird | $175 → $185 | Maintains | Outperform | |||
04/21/2023 | 75.74% | Stifel | $133 → $150 | Maintains | Hold | |||
04/17/2023 | — | OTR Global | — | — | Upgrade | Mixed → Positive | ||
02/17/2023 | 55.83% | Stifel | $107 → $133 | Maintains | Hold | |||
02/17/2023 | 105.04% | Baird | $155 → $175 | Maintains | Outperform | |||
01/12/2023 | 45.28% | UBS | $107 → $124 | Maintains | Neutral | |||
01/12/2023 | 69.89% | Piper Sandler | $118 → $145 | Maintains | Overweight | |||
01/11/2023 | 81.6% | Baird | $150 → $155 | Maintains | Outperform | |||
12/16/2022 | 38.25% | Piper Sandler | $95 → $118 | Maintains | Overweight | |||
11/14/2022 | 75.74% | Baird | $100 → $150 | Maintains | Outperform | |||
11/04/2022 | 17.16% | Baird | $95 → $100 | Maintains | Outperform | |||
09/21/2022 | — | Exane BNP Paribas | — | Initiates | → Neutral |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Crocs (CROX)?
El último precio objetivo de Crocs (NASDAQ:CROX) fue comunicado por UBS el agosto 11, 2025. La firma de analistas fijó un precio objetivo para $85.00 que espera CROX a fall dentro de 12 meses (un posible -0.41% downside). 38 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Crocs (CROX)?
La última calificación de analistas para Crocs (NASDAQ:CROX) fue proporcionada por UBS, y Crocs mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Crocs (CROX)?
La última revisión al alza de Crocs Inc se produjo en marzo 12, 2025, cuando Loop Capital elevó su precio objetivo a $110. Loop Capital anteriormente tenía a hold para Crocs Inc.
¿Cuándo fue la última revisión a la baja de Crocs (CROX)?
La última revisión a la baja de Crocs Inc se produjo en agosto 8, 2025, cuando Stifel cambió su precio objetivo de $127 a $85 para Crocs Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Crocs (CROX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Crocs, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Crocs se registró el agosto 11, 2025, por lo que la próxima calificación estará disponible en torno al agosto 11, 2026.
¿Es correcta la calificación de los analistas sobre Crocs (CROX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Crocs (CROX) fue un mantuvo con un precio objetivo de $110.00 a $85.00. El precio actual al que cotiza Crocs (CROX) es de $85.35, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.